Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 17 studies. P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded P1053: Evaluation PI-Containing vs. Non-PI-Containing Salvage Regimens. DAIDS Number 10131 Research Area Other Study Status Concluded P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded P1034: Comparative trial of protease-containing and protease-sparing HAART regimes DAIDS Number 10043 Research Area Other Study Status Concluded P1017: PEG-Intron in HIV+Children DAIDS Number 10317 Research Area Other Study Status Concluded P1007: Phase I Salvage Therapy DAIDS Number 10315 Research Area Other Study Status Concluded P1004s: Intensive PK substudies in ACTG 403 DAIDS Number 10313 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 Current page 2
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1053: Evaluation PI-Containing vs. Non-PI-Containing Salvage Regimens. DAIDS Number 10131 Research Area Other Study Status Concluded
P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded
P1034: Comparative trial of protease-containing and protease-sparing HAART regimes DAIDS Number 10043 Research Area Other Study Status Concluded
P1004s: Intensive PK substudies in ACTG 403 DAIDS Number 10313 Research Area Other Study Status Concluded
